Literature DB >> 31478975

PD-1 Expression and Function of T-Cell Subsets in TILs From Human Lung Cancer.

Yong Gu1, Si Yuan Sheng2, Ying Ying Tang2, Chuan Gang Lu1, Jian Yong Zou1, Yan Feng Wang1, Hai Hong2.   

Abstract

On the basis of the autologous tumor-infiltrating lymphocytes (TILs) or genetically modified TILs for adoptive cell therapy have received more attention. Programmed cell death protein 1 (PD-1) expression on the T cells exert complex response during the tumor immune response. But the composition and function of PD-1T-cell subsets in TILs from human lung cancer still limited. In blood and TILs from human lung cancer patients, we confirmed that PD-1 is expressed in higher levels in CD4T-cell subsets than in CD8T-cell subsets. To further analyze the function of PD-1T cells in TILs, we observed the cytokine production in different T-cell subsets. We found that higher interferon-γ and granzyme B production in CD4/CD8PD-1T-cell subsets in TILs than in peripheral blood mononuclear cells (PBMCs); except for PD-1Tscm, higher tumor necrosis factor-α production was observed in PD-1T-cell subsets in TILs than in PBMCs; the expression level of interleukin-17 were lower in PD-1T cells in TILs than in PBMCs; and perforin expression was significantly reduced in CD4PD-1T cells subsets in TILs compared with peripheral blood. Clarify elucidating the composition and function of PD-1T-cell subsets in TILs will have great value in clinical application for evaluating the sensitivity to PD-1 blockade and selecting the promising candidate T-cell subsets in TILs for combination immunotherapy in human lung cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31478975     DOI: 10.1097/CJI.0000000000000292

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  6 in total

Review 1.  The state of the art for artificial intelligence in lung digital pathology.

Authors:  Vidya Sankar Viswanathan; Paula Toro; Germán Corredor; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Pathol       Date:  2022-06-20       Impact factor: 9.883

2.  Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of bone.

Authors:  Jasna Metovic; Laura Annaratone; Alessandra Linari; Simona Osella-Abate; Chiara Musuraca; Francesca Veneziano; Chiara Vignale; Luca Bertero; Paola Cassoni; Nicola Ratto; Alessandro Comandone; Giovanni Grignani; Raimondo Piana; Mauro Papotti
Journal:  Cancer Immunol Immunother       Date:  2020-05-06       Impact factor: 6.968

3.  Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.

Authors:  Eriko Katsuta; Li Yan; Mateusz Opyrchal; Pawel Kalinski; Kazuaki Takabe
Journal:  Ther Adv Med Oncol       Date:  2021-04-05       Impact factor: 8.168

4.  Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC.

Authors:  Daiki Ikarashi; Tamio Okimoto; Takehito Shukuya; Hiroko Onagi; Takuo Hayashi; Sara L Sinicropi-Yao; Joseph M Amann; Tetsuya Nakatsura; Shigehisa Kitano; David P Carbone
Journal:  JTO Clin Res Rep       Date:  2021-09-20

5.  Increased TIGIT+PD‑1+CXCR5CD4+T cells are associated with disease activity in rheumatoid arthritis.

Authors:  Qing Luo; Peng Fu; Yongqin Guo; Biqi Fu; Yang Guo; Qingshui Huang; Zikun Huang; Junming Li
Journal:  Exp Ther Med       Date:  2022-08-31       Impact factor: 2.751

6.  Effect of Sintilimab combined with Chemotherapy on Tumor Markers and Immune Function of advanced non-small cell lung cancer.

Authors:  Xiaoyan Liang; Zhangfeng Wei
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.